Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H4758 Latest Draft

Bill / Introduced Version Filed 06/13/2024

                            1 of 47
FILED ON: 6/13/2024
HOUSE . . . . . . . . . . . . . . . No. 4758
House bill No. 4743, as change by the House committee on Bills in the Third Reading, and as 
amended and passed to be engrossed by the House. June 13, 2024.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to treatments and coverage for substance use disorder and recovery coach 
licensure.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority 
of the same, as follows:
1 SECTION A1. Chapter 32A of the General Laws is hereby amended by striking out 
2section 17Q and inserting in place thereof the following section:-
3 Section 17Q. (a) The commission shall develop a plan to provide active or retired 
4employees insured under the group insurance commission adequate coverage and access to a 
5broad spectrum of pain management services, including, but not limited to, non-medication, non-
6surgical treatment modalities and non-opioid medication treatment options that serve as 
7alternatives to opioid prescribing, in accordance with guidelines developed by the division of 
8insurance.
9 (b) No such coverage offered by the commission shall, relative to pain management 
10services identified by the commission pursuant to subsection (a), require a member to obtain a 
11preauthorization for non-medication, non-surgical treatment modalities that include restorative  2 of 47
12therapies, behavioral health approaches or integrative health therapies, including acupuncture, 
13chiropractic treatments, massage and movement therapies.
14 (c)(1) The plan pursuant to subsection (a) shall be subject to review by the division of 
15insurance. In its review, the division shall consider the adequacy of access to a broad spectrum of 
16pain management services and any policies that may create unduly preferential coverage to 
17prescribing opioids without other pain management modalities.
18 (2) Any coverage offered by the commission to an active or retired employee of the 
19commonwealth insured under the group insurance commission shall not establish utilization 
20controls, including preauthorization or step therapy requirements, for clinically appropriate non-
21opioid drugs approved by the federal Food and Drug Administration for the treatment or 
22management of pain that are more restrictive or extensive than the least restrictive or extensive 
23utilization controls applicable to any clinically appropriate opioid drug.
24 (d) The commission shall annually distribute educational materials to providers within 
25their network and to members about the pain management access plan and shall make 
26information about its plan publicly available on its website.
27 SECTION 1. Said chapter 32A is hereby further amended by inserting after section 17S 
28the following 2 sections:- 
29 Section 17T. (a) Any coverage offered by the commission to an active or retired 
30employee of the commonwealth insured under the group insurance commission shall provide 
31coverage for prescribed or dispensed opioid antagonists, as defined in section 19B of chapter 
3294C and used in the reversal of overdoses caused by opioids, which shall be deemed medically  3 of 47
33necessary and shall not require prior authorization; provided, however, that a prescription from a 
34health care practitioner shall not be required for coverage of opioid antagonists. An opioid 
35antagonist used in the reversal of overdoses caused by opioids shall not be subject to any 
36deductible, coinsurance, copayments or out-of-pocket limits; provided, however, that cost-
37sharing shall be required if the applicable plan is governed by the federal Internal Revenue Code 
38and would lose its tax-exempt status as a result of the prohibition on cost-sharing for this service. 
39 (b) The commission shall provide coverage for an opioid antagonist used in the reversal 
40of overdoses caused by opioids as a medical benefit when dispensed by the health care facility in 
41which the opioid antagonist was prescribed and shall provide coverage as a pharmacy benefit for 
42an opioid antagonist used in the reversal of overdoses caused by opioids dispensed by a 
43pharmacist, including an opioid antagonist dispensed pursuant to section 19B of chapter 94C; 
44provided, however, that the rate to be reimbursed under the medical benefit shall not exceed the 
45commission’s average in-network pharmacy benefit rate and the health care facility shall not 
46balance bill the patient.
47 Section 17U. (a) The commission shall provide to any active or retired employee of the 
48commonwealth who is insured under the group insurance commission coverage for the provision 
49of services by a recovery coach licensed or otherwise authorized to practice pursuant to chapter 
50111J, irrespective of the setting in which the services are provided; provided, that such services 
51shall be within the lawful scope of practice of a recovery coach. The contractual rate for these 
52services shall be not less than the prevailing MassHealth rate for recovery coach services. The 
53benefits in this section shall not be subject to any deductible, coinsurance, copayments or out-of-
54pocket limits; provided, however, that cost-sharing shall be required if the applicable plan is 
55governed by the federal Internal Revenue Code and would lose its tax-exempt status as a result  4 of 47
56of the prohibition on cost-sharing for the service. Recovery coach services shall be deemed 
57medically necessary and shall not require prior authorization.
58 SECTION 2. Chapter 18 of chapter 94C of the General Laws, as appearing in the 2022 
59Official Edition, is hereby amended by striking out subsection (e) and inserting in place thereof 
60the following subsection:-
61 (e) Practitioners who prescribe controlled substances, except veterinarians, shall be 
62required, as a prerequisite to obtaining or renewing their professional licenses, to complete 
63appropriate training relative to: (i) effective pain management including, but not limited to: (A) 
64appropriate, available non-opioid alternatives for the treatment of pain; (B) the advantages and 
65disadvantages of the use of non-opioid treatment alternatives, considering a patient’s risk of 
66substance misuse; and (C) the options for referring or prescribing appropriate non-opioid 
67treatment alternatives based on the practitioner’s clinical judgment and following generally 
68accepted clinical guidelines, taking into consideration the preference and consent of the patient 
69and the educational information described in section 21; (ii) the risks of misuse and addiction 
70associated with opioid medication; (iii) the identification of patients at risk for substance misuse; 
71(iv) counseling patients about the side effects, risks, addictive nature and proper storage and 
72disposal of prescription medications; (v) the appropriate prescription quantities for prescription 
73medications that have an increased risk of misuse and addiction, including a patient’s option to 
74fill a prescription for a schedule II controlled substance in a lesser quantity than indicated on the 
75prescription pursuant to subsection (d¾); and (vi) opioid antagonists, overdose prevention 
76treatments and information to advise patients on both the use of and ways to access opioid 
77antagonists and overdose prevention treatments. The boards of registration for each professional 
78license that require this training shall, in consultation with the department, relevant stakeholders  5 of 47
79and experts in the treatment and management of acute and chronic pain, develop the standards 
80for appropriate training programs. For the purposes of this section, non-opioid treatment 
81alternatives shall include, but shall not be limited to, medications, restorative therapies, 
82interventional procedures, behavioral health approaches and complementary and integrative 
83treatments.
84 SECTION 3. Said chapter 94C is hereby further amended by striking out section 19C and 
85inserting in place thereof the following section:-
86 Section 19C. The board of registration in pharmacy shall promulgate regulations 
87requiring pharmacies located in areas with high incidents of opiate overdose, as determined by 
88the board in consultation with the department, to maintain a continuous supply of opioid 
89antagonists, as defined in section 19B; provided, that the continuous supply of opioid antagonists 
90shall include opioid antagonists that are approved by the federal Food and Drug Administration 
91to be sold over the counter without a prescription; provided further, that such pharmacies shall 
92notify the department if the supply or stock of opioid antagonist doses is insufficient to enable 
93compliance with maintaining a continuous supply of opioid antagonists. 
94 SECTION 4. Said chapter 94C is hereby further amended by inserting after section 19D 
95the following section:- 
96 Section 19D½. (a) For the purposes of this section, the following words shall, unless the 
97context clearly requires otherwise, have the following meanings: 
98 “Opioid antagonist”, as defined in section 19B. 6 of 47
99 “Substance use disorder treatment facility”, a facility licensed or approved by the 
100department to offer treatment for substance use disorder, including, but not limited to: (i) 
101withdrawal management services; (ii) clinical stabilization services; (iii) transitional support 
102services; (iv) residential support services; (v) community behavioral health center services; (vi) 
103office-based opioid or addiction treatment services; or (vii) outpatient substance use disorder 
104services.
105 (b) Upon discharge of a patient from a substance use disorder treatment facility, the 
106facility shall educate the patient on the use of opioid antagonists and dispense not less than 2 
107doses of an opioid antagonist to the patient or a legal guardian.
108 (c) The commissioner may promulgate rules and regulations necessary to implement this 
109section.
110 SECTION 5. Section 21 of said chapter 94C, as appearing in the 2022 Official Edition, is 
111hereby amended by striking out the third paragraph and inserting in place thereof the following 
112paragraph:-
113 The department, in consultation with relevant stakeholders and experts in the treatment 
114and management of acute and chronic pain, and based in part on the Pain Management Best 
115Practices Inter-Agency Task Force Report issued by the United States Department of Health and 
116Human Services, shall produce and distribute either in written or electronic form to pharmacies, 
117not including institutional pharmacies, pamphlets for consumers relative to narcotic drugs, 
118specifically opiates, that include educational information related to: (i) pain management and the 
119use and availability of non-opioid alternatives for the treatment of acute and chronic pain, 
120including, but not limited to: (A) information on available non-opioid alternatives for the  7 of 47
121treatment of pain, including non-opioid medications and non-pharmacological therapies; and (B) 
122the advantages and disadvantages of the use of such non-opioid treatment alternatives; (ii) the 
123consumer’s option to fill a prescription for a schedule II controlled substance in a lesser quantity 
124than indicated on the prescription pursuant to subsection (d¾) of section 18; (iii) misuse and 
125abuse by adults and children; (iv) the risk of dependency and addiction; (v) proper storage and 
126disposal; (vi) addiction support and treatment resources; (vii) the telephone helpline operated by 
127the bureau of substance addiction services established in section 18 of chapter 17; (viii) risks of 
128unintended overdoses associated with prescription opioid use, including, but not limited to: (A) 
129mixing any opioid with respiratory depressants, including, but not limited to, alcohol, 
130benzodiazepines and stimulants; and (B) changes in personal tolerance levels for persons with a 
131history of overdose; and (ix) risk reduction measures to prevent, respond to and reverse an opioid 
132overdose. A pharmacist shall distribute the pamphlet when dispensing a narcotic or controlled 
133substance contained in schedule II or III; provided, however, that pharmacists shall not be 
134required to distribute the pamphlet if: (i) the patient is receiving outpatient palliative care 
135pursuant to section 227 of chapter 111; (ii) the patient is a resident of a long-term care facility; or 
136(iii) the narcotic or controlled substance is prescribed for use in the treatment of substance use 
137disorder or opioid dependence. For the purposes of this section, non-opioid treatment alternatives 
138shall include, but shall not 	be limited to, medications, restorative therapies, interventional 
139procedures, behavioral health approaches and complementary and integrative treatments.
140SECTION 6. Said chapter 	94C is hereby further amended by inserting after section 34A the 
141following section:- 
142 Section 34A½. (a) As used in this section, the 	following words shall, unless the context 
143clearly requires otherwise, have the following meanings: 8 of 47
144 “Drug testing services”, the use of testing equipment to identify or analyze the strength, 
145effectiveness or purity of a controlled substance prior to its injection, inhalation or ingestion by 
146another person to determine whether the controlled substance contains chemicals, toxic 
147substances or hazardous compounds.
148 “Testing equipment”, including, but not limited to: fentanyl test strips, colorimetric 
149reagents, high-performance liquid chromatography, gas chromatography and mass spectrometry.
150 (b)(1) A person acting in good faith and within the scope of their role providing or 
151assisting in the provision of harm reduction services as an owner, employee, intern, volunteer or 
152third-party contractor of an entity providing harm reduction services may provide or assist in 
153drug testing services to an individual to ensure that a controlled substance in the possession of 
154the individual and exclusively for that individual’s personal use does not contain dangerous 
155chemicals, toxic substances or hazardous compounds likely to cause an accidental overdose.
156 (2) A person acting in good faith and within the scope of their role providing or assisting 
157in the provision of harm reduction services as an owner, employee, intern, volunteer or third-
158party contractor of an entity providing harm reduction services who provides or assists in the 
159provision of drug testing services pursuant to this section shall not be charged or prosecuted 
160pursuant to sections 32I, 34 or 40.
161 (3) A person acting in good faith and within the scope of their role providing or assisting 
162in the provision of harm reduction services as an owner, employee, intern, volunteer or third-
163party contractor of an entity providing harm reduction services who provides or assists in drug 
164testing services pursuant to this section shall: (i) not be held civilly liable for drug testing 
165services unless for gross negligence or willful misconduct in the execution of the drug testing  9 of 47
166services; and (ii) not be subject to any criminal or civil liability or any professional disciplinary 
167action; provided, however, that this section shall not apply to acts of gross negligence or willful 
168or wanton misconduct.
169 (c) An individual acting in good faith who seeks drug testing services of a controlled 
170substance in their possession and intended exclusively for their personal use from a person acting 
171in good faith and within the scope of their role providing, or assisting in the provision of, harm 
172reduction services as an owner, employee, intern, volunteer or third-party contractor of an entity 
173providing harm reduction services shall not be charged or prosecuted pursuant to sections 32I, 34 
174or 40 while on the premises where the drug testing services are conducted.
175 SECTION 7. Section 25J½ of chapter 111 of the General Laws, as appearing in the 2022 
176Official Edition, is hereby amended by inserting after the first paragraph the following 
177paragraph:-
178 Upon discharge of a patient from an acute care hospital or satellite emergency facility 
179who has: (i) a history of or is actively using opioids; (ii) been diagnosed with opioid use 
180disorder; or (iii) experienced an opioid-related overdose, the acute care hospital or satellite 
181emergency facility shall educate the patient on the use of opioid antagonists, as defined in section 
18219B of chapter 94C, and prescribe or dispense not less than 2 doses of an opioid antagonist to the 
183patient or a legal guardian and notify the patient’s primary care physician or preferred care 
184provider, if known and in consultation with the patient, of the prescribed or dispensed opioid 
185antagonist.
186 SECTION 8. Said chapter 111, as so appearing, is hereby amended by inserting after 
187section 110C the following section:- 10 of 47
188 Section 110D. (a) The department shall collect and provide data to the department of 
189children and families and the office of the child advocate on all births of infants affected by 
190prenatal substance exposure in a form and manner consistent with any requirements of the 
191federal Child Abuse Prevention and Treatment Act; provided, that said data shall not include 
192personally identifiable information. 
193 (b) Annually, not later than April 1, the department, in consultation with the department 
194of children and families and the office of the child advocate, shall file with the clerks of the 
195house of representatives and the senate, the house and senate committees on ways and means, the 
196joint committee on children, families and person with disabilities and the joint committee on 
197mental health, substance use and recovery a report, along with any recommendations, examining 
198the prevalence of births of infants identified as affected by prenatal substance exposure or fetal 
199alcohol spectrum disorder, 	including, but not limited to: (i) any gaps in services for perinatal 
200patients or such infants; (ii) an examination of child abuse and neglect reports related to an 
201infant’s prenatal exposure to substances, including those that were ultimately screened out by the 
202department of children and families; (iii) an examination of child abuse and neglect reports made 
203pursuant to section 51A of chapter 119 related to an infant’s prenatal exposure to substances; and 
204(iv) any recommended changes, including legislative or regulatory changes, that may be 
205necessary to ensure the ongoing health, safety and wellbeing of perinatal patients and infants. If 
206applicable, the department, in consultation with the department of children and families and the 
207office of the child advocate, shall provide recommendations to address disparate impacts of the 
208safety and wellbeing of infants identified as affected by prenatal substance exposure or fetal 
209alcohol spectrum disorder. 11 of 47
210 SECTION 9. Section 7 of chapter 111E of the General Laws, as so appearing, is hereby 
211amended by inserting after the word “basis”, in line 28, the following words:- , as determined by 
212the department to be consistent with section 4 of chapter 151B and sufficient to ensure the needs 
213of such residents are met and such residents have adequate access to such a facility,.
214 SECTION 10. The 	General Laws are hereby amended by striking out chapter 111J and 
215inserting in place thereof the following chapter:-
216 CHAPTER 111J
217 ALCOHOL AND DRUG COUNSELORS; RECOVERY COACHES.
218 Section 1. As used in this chapter, the following words shall, unless the context clearly 
219requires otherwise, have the following meanings:
220 “Applicant”, an individual seeking licensure under this chapter.
221 “Approved continuing education”, continuing education approved by the department, 
222including research and training programs, college and university courses, in-service training 
223programs, seminars and conferences designed to maintain and enhance the skills of licensees.
224 “Approved program”, a program approved by the department for the education and 
225training of licensees.
226 “Approved work experience”, supervised work experience, approved by the department, 
227in the practice area for which an applicant seeks licensure.
228 “Department”, the department of public health.
229 “Licensee”, an individual who is licensed under this chapter. 12 of 47
230 “Licensed alcohol and drug counselor I”, a person licensed by the department to conduct 
231an independent practice of alcohol and drug counseling and to provide supervision to other 
232alcohol and drug counselors. A licensed alcohol and drug counselor I shall have: (i) received a 
233master’s or doctoral degree in behavioral sciences, which included a supervised counseling 
234practicum that meets the requirements established by the department or such equivalent 
235educational credits as may be established by the department; (ii) at least 3 years of approved 
236work experience; and (iii) passed a licensing examination approved by the department.
237 “Licensed alcohol and drug counselor II”, a person licensed by the department to practice 
238alcohol and drug counseling under clinical supervision. A licensed alcohol and drug counselor II 
239shall have: (i) completed an approved program of education, which included a supervised 
240counseling practicum that meets the requirements established by the department or such 
241equivalent educational credits as may be established by the department; (ii) at least 3 years of 
242approved work experience; and (iii) passed a licensing examination approved by the department.
243 “Licensed recovery coach”, a person with lived experience who is licensed by the 
244department to practice recovery coaching using shared understanding, respect and mutual 
245empowerment to help others become and stay engaged in the process of recovery from a 
246substance use disorder. A licensed recovery coach shall: (i) have completed an approved 
247program of education, including approved work experience that meets the requirements 
248established by the department; (ii) demonstrate at least 2 years of sustained recovery; and (iii) 
249have met all education, training and experience requirements and qualifications as established by 
250the department. 13 of 47
251 “Lived experience”, the experience of addiction and recovery from a substance use 
252disorder.
253 Section 2. (a) The department shall establish and administer a program for the licensure 
254of alcohol and drug counselors and recovery coaches. The department shall: (i) establish the 
255licensure requirements for 	licensed alcohol and drug counselors practicing in the commonwealth; 
256(ii) establish the licensure requirements for licensed recovery coaches practicing in the 
257commonwealth; (iii) evaluate the qualifications of applicants for licensure; (iv) supervise 
258licensing examinations, where applicable; (v) establish and collect fees for licensing and 
259examination, where applicable; (vi) grant and issue licenses to applicants who satisfy the 
260department’s requirements for licensure; (vii) establish continuing education requirements; (viii) 
261investigate complaints; (ix) take appropriate disciplinary action to protect the public health, 
262safety and welfare; and (x) perform other functions and duties as may be necessary to carry out 
263this chapter.
264 (b) The department shall establish requirements for licensed alcohol and drug counselors 
265I and licensed alcohol and drug counselors II and may establish other reasonable classifications 
266for alcohol and drug counselors as it finds necessary and appropriate, taking into consideration 
267different levels of education, training and work experience.
268 (c) The department shall establish requirements for licensed recovery coaches, including, 
269but not limited to, establishing an ethical code of conduct for recovery coaches, and may 
270establish other reasonable classifications for recovery coaches as it finds necessary and 
271appropriate, taking into consideration different levels of education, training and work experience. 14 of 47
272 (d) The department shall approve and issue certificates of approval of programs for the 
273training of alcohol and drug counselors. The department shall maintain a list of approved 
274programs and a current roster of persons serving as licensed alcohol and drug counselors in the 
275commonwealth.
276 (e) The department shall approve and issue certificates of approval of programs for the 
277training of recovery coaches. The department shall maintain a list of approved programs and a 
278current roster of persons serving as licensed recovery coaches in the commonwealth.
279 (f) The department shall promulgate rules and regulations as it deems necessary to 
280implement the provisions of this chapter, including, but not limited to, rules and regulations 
281establishing the educational and professional requirements for licensing individuals under this 
282chapter, establishing fees for licensing and examination, where applicable, and governing the 
283practice and employment of licensees to promote the public health, safety and welfare.
284 Section 3. (a) Each applicant shall furnish the department with proof of satisfactory 
285completion of the educational, training and experience requirements for licensure, including 
286completion of an approved program and approved work experience and proof of having passed 
287any licensing examinations required by the department; provided, that the department may 
288establish additional requirements for licensure and exemptions by regulation. 
289 (b) A licensee shall apply biennially to the department for license renewal. A licensee 
290seeking license renewal shall submit proof of having successfully completed the requirements for 
291approved continuing education as may be established by the department. 15 of 47
292 (c) Applications for licenses and renewals thereof shall be submitted in accordance with 
293procedures established by the department. The department may establish fees for license 
294applications or renewals.
295 Section 4. (a) Except as otherwise provided for in this chapter or by regulation of the 
296department, persons not licensed or otherwise exempt from licensing shall not hold themselves 
297out as a licensed recovery coach and shall not use the title, initials, abbreviations, insignia or 
298description of a licensed recovery coach or practice or attempt to practice recovery coaching 
299unless otherwise authorized by law or rule or regulation of the department. Whoever engages in 
300any such unauthorized action shall be subject to a fine of not less than $500. The department may 
301bring a petition in superior court to enjoin such action or any other violation of this chapter or a 
302regulation of the department.
303 (b) The following individuals pursuing a recovery coach license who meet the 
304requirements for licensed recovery coach applicants as set forth in this chapter or in rules or 
305regulations of the department may practice without a license in order to obtain the requisite hours 
306of supervised work experience needed to obtain such 	license:
307 (i) an educational psychologist, marriage and family therapist, alcohol and drug 
308counselor, mental health counselor, nurse practitioner, occupational therapist, physician, 
309physician assistant, practical nurse, psychologist, registered nurse, rehabilitation counselor or 
310social worker;
311 (ii) an employee or other agent of a recognized academic institution or employee 
312assistance program or a federal, state, county or local government institution, program, agency or 
313facility or school committee, school district, school board or board of regents while performing  16 of 47
314recovery coach duties solely for the respective entity or under the jurisdiction and supervision of 
315such entity; and
316 (iii) an employee of a program or facility approved or licensed by the department 
317pursuant to chapters 111B and 111E; provided, however, that such individual shall perform 
318recovery coaching solely within or under the jurisdiction and supervision of such program or 
319facility.
320 (c) Nothing in this section shall be construed to prevent members of peer groups or self-
321help groups from performing peer counseling or self-help activities that may be included within 
322the practice recovery coaching; provided, however, that no members of peer groups or self-help 
323groups who are not so credentialed shall use a title stating or implying that such person is a 
324licensed recovery coach.
325 Section 5. (a) Except as otherwise provided for in this chapter or by regulation, a person 
326who is not licensed or is otherwise exempt from licensing shall not hold themself out as a 
327licensed alcohol and drug counselor and shall not use the title, initials or description of a licensed 
328alcohol and drug counselor or practice or attempt to practice alcohol and drug counseling. 
329Whoever engages in any such unauthorized action shall be subject to a fine of not less than $500. 
330The department may bring a petition in superior court to enjoin such action or any other violation 
331of this chapter or a regulation of the department.
332 (b) The following individuals shall be exempt from the licensing requirements for alcohol 
333and drug counseling under this chapter: 17 of 47
334 (i) an educational psychologist, marriage and family therapist, mental health counselor, 
335nurse practitioner, occupational therapist, physician, physician assistant, practical nurse, 
336psychologist, registered nurse, rehabilitation counselor and social worker;
337 (ii) an employee or other agent of a recognized academic institution or employee 
338assistance program or a federal, state, county or local government institution, program, agency or 
339facility or school committee, school district, school board or board of regents while performing 
340alcohol and drug counseling duties solely for the respective entity or under the jurisdiction of 
341such entity; provided, however, that a license pursuant to this chapter need not be a requirement 
342for employment in any state, county or municipal agency; and
343 (iii) an employee of a treatment program or facility licensed or approved by the 
344department pursuant to chapters 111B and 111E; provided, however, that such individual shall 
345perform alcohol and drug counseling solely within or under the jurisdiction of such program or 
346facility.
347 (c) Nothing in this section shall be construed to prevent qualified members of other 
348professions, including attorneys, Christian Science practitioners or members of the clergy, from 
349providing alcohol or drug counseling consistent with accepted standards of their respective 
350professions; provided, however, that no such person shall use a title stating or implying that such 
351person is a licensed alcohol and drug counselor.
352 (d) Nothing in this section shall be construed to prevent members of peer groups or self-
353help groups from performing peer group or self-help activities; provided, however, that no such 
354person shall use a title stating or implying that such person is a licensed alcohol and drug 
355counselor. 18 of 47
356 Section 6. (a) The department shall establish procedures for consumers to file written 
357complaints regarding an individual licensed under this chapter. The department shall investigate 
358all complaints relating to the proper practice of a person holding a license under this chapter and 
359all complaints relating to any violation of this chapter or regulation of the department.
360 (b) The department may conduct an adjudicatory proceeding pursuant to chapter 30A, but 
361shall not have the power to issue, vacate, modify or enforce subpoenas pursuant to section 12 of 
362said chapter 30A. The department may, after a hearing pursuant to said chapter 30A, deny, refuse 
363renewal, revoke, limit or suspend a license or otherwise discipline a licensee; provided, however, 
364the department may suspend the license of a licensee who poses an imminent danger to the 
365public; provided further, that the licensee shall be afforded a hearing within 7 business days to 
366determine whether the action is warranted; and provided further, that the department shall 
367conduct its proceedings in accordance with the provisions of this chapter and said chapter 30A. 
368Grounds for denial, refusal to renew, revocation, limitation, suspension or other discipline shall 
369include the following: 
370 (i) fraud or misrepresentation in obtaining a license;
371 (ii) criminal conduct which the department determines to be of such a nature as to render 
372such person unfit to practice as licensed as evidenced by criminal proceedings resulting in a 
373conviction, guilty plea or plea of nolo contendere or an admission of sufficient facts;
374 (iii) violation of any law or rule or regulation of the department governing the practice of 
375the licensee;
376 (iv) violation of ethical standards which the department determines to be of such a nature 
377as to render such person unfit to practice as a licensee; or 19 of 47
378 (v) other just and sufficient cause that the department determines would render a person 
379unfit to practice as a licensee.
380 (c) Where denial, refusal to renew, revocation or suspension is based solely on the failure 
381of the licensee to timely file an application or pay prescribed fees or to maintain insurance 
382coverage as required by law or regulation, the department may act without first granting the 
383applicant or licensee a hearing.
384 Section 7. (a) Examinations for licensure, where applicable, shall be conducted at least 
385twice per year at times and places designated by the department. Examinations for licensure, 
386where applicable, shall be written; provided, however, that portions thereof may be conducted 
387orally. A person who has failed an examination may be admitted to the next subsequent 
388examination.
389 (b) The department may accept, in lieu of its own examination, a current certificate of 
390any recognized certifying body issued on the basis of an examination satisfactory to the 
391department; provided, however, that the standards of such body shall be at least as stringent as 
392those established by the department.
393 Section 8. (a) The department may issue a license without examination to an applicant 
394who meets the requirements for licensure established by the department if such applicant is 
395licensed or certified in alcohol and drug counseling or in recovery coaching or a comparable 
396field in another state wherein the requirements for licensure shall be determined by the 
397department to be equivalent to or in excess of the requirements of this chapter. 
398 (b) The department may authorize an alcohol and drug counselor or a recovery coach to 
399practice by reciprocity.  20 of 47
400 (c) The department shall promulgate rules and regulations as may be necessary to 
401implement this section.
402 Section 9. (a) There shall be a recovery coach advisory council within the department to 
403assist and support the department in carrying out this chapter by planning, guiding and 
404coordinating the components of the practice of recovery coaching; provided, that the council may 
405advise the department on other such matters related to the practice of repractice of alcohol and 
406drug counseling and the inclusion of people with lived experience in guiding such practices.
407 (b) The advisory council shall consist of the following members: the director of the 
408bureau of substance addiction services, or a designee, who shall serve as chair; and 7 members 
409appointed by the secretary of health and human services, 4 of whom shall be employed as 
410recovery coaches, recovery coach supervisors or recovery coach educators and shall be, to the 
411extent possible, representative of the demographic diversity of the commonwealth, including, but 
412not limited to, diversity in race, ethnicity, gender, gender identity, sexual orientation, age, 
413disability, geographical region, workplace and history of involvement with the criminal legal 
414system, 1 of whom shall be a representative of the Massachusetts Board of Substance Abuse 
415Counselor Certification, 1 of whom shall represent a health plan and 1 of whom shall be a person 
416with lived experience who has received or is receiving recovery coaching services. Members of 
417the advisory council shall be residents of the commonwealth.
418 Section 10. The bureau of substance addiction services shall establish a comprehensive 
419peer support program to provide mentorship, technical assistance and support resources for the 
420wellbeing of recovery coaches, including, but not limited to, peer support specialists, peer 
421recovery coaches and recovery support navigators. The program shall include, but shall not be  21 of 47
422limited to: (i) a network for peer-to-peer trainings, education, mentorship, counseling and 
423support; (ii) educational and other clinical support materials; (iii) technical assistance for 
424licensure, certification, credentialing and other employment and practice requirements; and (iv) 
425billing technical assistance for organizations that employ recovery coaches.
426 SECTION 10A. Chapter 112 of the General Laws is hereby amended by inserting after 
427section 52G the following section:-
428 Section 52H. (a) For the purpose of this section, the following words shall, unless the 
429context clearly requires otherwise, have the following meanings:
430 “Board”, the board of registration in dentistry established in section 19 of chapter 13.
431 “Continuing care”, guidance, support, toxicology collection and accountability through a 
432formal monitoring contract concurrent with or following an evaluation and treatment process.
433 “Peer review committee”, a committee of healthcare providers which evaluates or 
434improves the quality of health care rendered by providers of health care services and evaluates 
435and assists health care providers impaired or allegedly impaired by reason of alcohol, drugs, 
436physical disability, mental instability or otherwise.
437 “Substantive non-compliance”, a pattern of non-compliance or dishonesty in continuing 
438care monitoring or an episode of non-compliance which could place patients at risk.
439 (b)(1) The board is hereby authorized and directed to offer a remediation program for 
440dentists and dental hygienists. 22 of 47
441 (2) The board shall select 1 or more providers to serve as designated remediation 
442programs.
443 (3) The board shall establish: (i) criteria for the acceptance, denial or termination of 
444registered dentists and dental hygienists in the program; and (ii) an outreach program to identify 
445registered dentists and dental hygienists who may have a substance use disorder and to provide 
446education about the remediation program.
447 (4) No member of the board shall be employed by or volunteer for the program.
448 (c)(1) A remediation program shall serve as a 	voluntary alternative to traditional 
449disciplinary actions. Any registered dentist or dental hygienist in the commonwealth may request 
450to participate in the program.
451 (2) To be eligible for designation, a remediation program shall have demonstrable 
452experience in the field of substance use disorder and shall employ a licensed mental health 
453professional with experience in the treatment of substance use disorders.
454 (3) The remediation program shall have the following duties and responsibilities: (i) to 
455evaluate registered dentists and dental hygienists who request to participate in the program for 
456admission into the program; (ii) to agree to accept referrals from the board; (iii) to review and 
457designate treatment facilities and assessment services to which participants may be referred; (iv) 
458to receive and review information concerning a participant in the program; (v) to disclose to the 
459board aggregate data on compliance-based on ongoing recovery documentation; (vi) to provide 
460each participant, through contracted agreements, with an individualized remediation plan 
461according to guidelines developed through collaboration between the board and the remediation  23 of 47
462program with regards to requirements for supervision; (vii) to provide information to dentists or 
463dental hygienists who request to participate in the program; and (viii) to establish an outreach 
464program to identify registered dentists and dental hygienists who may have a substance use or 
465other mental health disorder, and to provide education about the remediation program.
466 (4) A registered dentist or dental hygienist who requests to participate in the remediation 
467program shall agree to cooperate with the individualized remediation plan recommended by the 
468remediation program. The remediation program may report to the board the name and license 
469number of a registered dentist or dental hygienist who fails to comply with an individualized 
470remediation plan.
471 (5) After the remediation program, in its discretion, has determined that a registered 
472dentist or dental hygienist has successfully completed an individualized remediation plan 
473through the program, the board shall seal all records pertaining to the participation of the 
474registered dentist or dental hygienist in the program. No record shall be sealed sooner than 5 
475years from the participant’s date of entry into the program. All board and remediation program 
476records of a participant’s involvement in the program shall be kept confidential and shall not be 
477subject to discovery or subpoena in any civil, criminal, legislative or administrative proceeding 
478without the prior written consent of the participant.
479 (6) The designated remediation programs shall be confidential and shall offer a means of 
480recovery and rehabilitation without the loss of a license by providing access to early 
481identification, intervention, evaluation, monitoring, referral to appropriate intervention programs 
482and treatment services, and earned advocacy, when appropriate, of licensees with potentially 
483impairing illness, ideally prior to functional impairment. 24 of 47
484 (7) In accordance with peer review law, proceedings, reports and records of the 
485remediation program shall be confidential pursuant to section 240. Such records shall not to be 
486disclosed, and shall not subject to subpoena or discovery, and shall not be introduced into 
487evidence in any judicial or administrative proceeding, subject to paragraph (4) and (5).
488 (8) No employee or volunteer member of the remediation program who is licensed to 
489practice by the department of public health division of professional licensure or by the board 
490shall have had any type of disciplinary or enforcement action taken against them by their 
491respective licensing board, during the 5 years preceding their appointment to the program.
492 SECTION 11. Chapter 118E of the General Laws is hereby amended by inserting after 
493section 10Q the following 2 sections:- 
494 Section 10R. The division and its contracted health insurers, health plans, health 
495maintenance organizations, behavioral health management firms and third-party administrators 
496under contract to a Medicaid managed care organization, accountable care organization or 
497primary care clinician plan shall provide coverage for prescribed or dispensed opioid antagonists, 
498as defined in section 19B of chapter 94C, which shall be deemed medically necessary and shall 
499not require prior authorization; provided, however, that a prescription from a health care 
500practitioner shall not be required for coverage of opioid antagonists. An opioid antagonist shall 
501not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; provided, 
502however, that cost-sharing 	shall be required if the applicable plan is governed by the federal 
503Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition on cost-
504sharing for this service.  25 of 47
505 (b) The division and its contracted health insurers, health plans, health maintenance 
506organizations, behavioral health management firms and third-party administrators shall provide 
507coverage for an opioid antagonist as a medical benefit when dispensed by the health care facility 
508in which the opioid antagonist was prescribed and shall provide coverage as a pharmacy benefit 
509for an opioid antagonist dispensed by a pharmacist, including an opioid antagonist dispensed 
510pursuant to section 19B of chapter 94C.
511 Section 10S. The division and its contracted health insurers, health plans, health 
512maintenance organizations, behavioral health management firms and third-party administrators 
513under contract to a Medicaid managed care organization, accountable care organization or 
514primary care clinician plan shall provide coverage for the provision of services by a recovery 
515coach licensed or otherwise authorized to practice pursuant to chapter 111J, irrespective of the 
516setting in which these services are provided; provided, that such services shall be within the 
517lawful scope of practice of a recovery coach. The benefits in this section shall not be subject to 
518any deductible, coinsurance, copayments or out-of-pocket limits. Recovery coach services shall 
519be deemed medically necessary and shall not require prior authorization.
520 SECTION 11A. Section 35 of chapter 123 of the General Laws, as appearing in the 2022 
521Official Edition, is hereby amended by inserting after the definition of “Facility” the following 
522definition:-
523 “Secured facility”, any public or private facility that provides care and treatment for a 
524person with alcohol or substance use disorder located within a correctional facility funded, 
525controlled, or administered by a county sheriff, or a private facility that provides a comparable 
526level of security. 26 of 47
527 SECTION 11B. Said section 35 of chapter 123, as so appearing, is hereby amended by 
528striking out the fourth, fifth and six paragraphs and inserting in place thereof the following 
529paragraphs:-
530 The secretary of health and human services shall ensure an adequate supply of suitable 
531beds for the treatment of alcohol or substance use disorders at facilities licensed or approved by 
532the department of public health or the department of mental health for persons ordered to be 
533committed under this section.
534 If the department of public health informs the 	court that there are no such suitable 
535facilities or if the court makes a specific finding that the only appropriate setting for treatment for 
536the person is a secure facility, then the person may be committed to a secure facility licensed or 
537approved by the department of public health or the department of mental health; provided 
538further, that such secure facilities shall be geographically distributed so as to provide access to 
539treatment in all regions of the commonwealth.
540 A person committed under this section shall, upon release, be encouraged to consent to 
541further treatment and shall be allowed voluntarily to remain in the facility for such purpose. The 
542department of public health shall maintain a roster of public and private facilities available, 
543together with the number of beds currently available and the level of security at each facility, for 
544the care and treatment of alcohol use disorder and substance use disorder and shall make the 
545roster available to the trial 	court.
546 SECTION 12. Subsection (a) of section 51A of chapter 119 of the General Laws, as 
547appearing in the 2022 Official Edition, is hereby amended by striking out the first paragraph and 
548inserting in place thereof the following paragraph:-  27 of 47
549 A mandated reporter shall immediately communicate with the department orally and 
550shall, within 48 hours, file a written report with the department detailing suspected abuse or 
551neglect if, in their professional capacity, they have reasonable cause to believe that a child is: (i) 
552suffering physical or emotional injury resulting from abuse inflicted upon them which causes 
553harm or substantial risk of harm to the child’s health or welfare including, but not limited to, 
554sexual abuse; (ii) suffering physical or emotional injury resulting from neglect including, but not 
555limited to, malnutrition; (iii) a sexually exploited child; or (iv) a human trafficking victim, as 
556defined by section 20M of chapter 233.
557 SECTION 13. Section 1 of chapter 151B of the General Laws, as so appearing, is hereby 
558amended by striking out subsection 17 and inserting in place thereof the following subsection:-
559 17. The term “handicap” means: (a) a physical or mental impairment which substantially 
560limits 1 or more major life activities of a person; (b) a record of having such impairment; (c) 
561being regarded as having such impairment; or (d) the lawful possession and clinically 
562appropriate taking of any medication that is: (i) approved by the federal Food and Drug 
563Administration for the treatment of an opioid-related substance use disorder, including, but not 
564limited to, an opioid agonist or a partial opioid agonist and used for the treatment of an opioid-
565related substance use disorder; (ii) obtained directly or pursuant to a valid prescription or order 
566from a practitioner, as defined in section 1 of chapter 94C; (iii) determined to be medically 
567necessary by a practitioner while acting in the course of professional practice; and (iv) offered in 
568accordance with a treatment plan that is reviewed by a practitioner at a frequency consistent with 
569appropriate clinical standards. The term handicap shall not include current, illegal use of a 
570controlled substance, as defined in said section 1 of said chapter 94C. For the purposes of this 
571subsection, the words “clinically appropriate” shall mean the taking of a prescribed medication  28 of 47
572for the treatment of an opioid-related substance use disorder when such drug is medically 
573indicated and intake is proportioned to the medical need.
574 SECTION 13A. Chapter 175 of the General Laws is hereby amended by striking out 
575section 47KK and inserting in place thereof the following section:-
576Section 47KK. (a) Any policy, contract, agreement, plan or certificate of insurance issued, 
577delivered or renewed within the commonwealth, which is considered creditable coverage under 
578section 1 of chapter 111M, shall develop a plan to provide adequate coverage and access to a 
579broad spectrum of pain management services, including, but not limited to, non-medication, non-
580surgical treatment modalities and non-opioid medication treatment options that serve as 
581alternatives to opioid prescribing, in accordance with guidelines developed by the division of 
582insurance.
583 (b) No such policy, contract, agreement, plan or certificate of insurance shall, relative to 
584pain management services identified by the carrier pursuant to subsection (a), require a member 
585to obtain a preauthorization for non-medication, non-surgical treatment modalities that include 
586restorative therapies, behavioral health approaches or integrative health therapies, including 
587acupuncture, chiropractic treatments, massage and movement therapies.
588 (c)(1) The plan pursuant to subsection (a) shall be subject to approval and shall be a 
589component of carrier accreditation by the division of insurance pursuant to section 2 of chapter 
590176O. In its review, the division shall consider the adequacy of access to a broad spectrum of 
591pain management services and any carrier policies that may create unduly preferential coverage 
592to prescribing opioids without other pain management modalities. 29 of 47
593 (2) No policy, contract, agreement, plan or certificate of insurance issued, delivered or 
594renewed within the commonwealth, which is considered creditable coverage under said section 1 
595of said chapter 111M, shall establish utilization controls, including preauthorization or step 
596therapy requirements, for clinically appropriate non-opioid drugs approved by the federal Food 
597and Drug Administration for the treatment or management of pain, that are more restrictive or 
598extensive than the least restrictive or extensive utilization controls applicable to any clinically 
599appropriate opioid drug.
600 (d) Carriers shall annually distribute educational materials to providers within their 
601networks and to members about the pain management access plan and shall make information 
602about their plans publicly available on their websites.
603 SECTION 14. Said chapter 175 is hereby further amended by inserting after section 
60447UU the following 2 sections:- 
605 Section 47VV. Any policy, contract, agreement, plan or certificate of insurance issued, 
606delivered or renewed within the commonwealth, which is considered creditable coverage under 
607section 1 of chapter 111M, shall provide coverage for prescribed or dispensed opioid antagonists, 
608as defined in section 19B of chapter 94C and used in the reversal of overdoses caused by opioids, 
609which shall be deemed medically necessary and shall not require prior authorization; provided, 
610however, that a prescription from a health care practitioner shall not be required for coverage of 
611opioid antagonists. An opioid antagonist used in the reversal of overdoses caused by opioids 
612shall not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; 
613provided, however, that cost-sharing shall be required if the applicable plan is governed by the  30 of 47
614federal Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition 
615on cost-sharing for this service. 
616 (b) The policy, contract, agreement, plan or certificate of insurance shall provide 
617coverage for an opioid antagonist used in the reversal of overdoses caused by opioids as a 
618medical benefit when dispensed by the health care facility in which the opioid antagonist was 
619prescribed and shall provide coverage as a pharmacy benefit for an opioid antagonist used in the 
620reversal of overdoses caused by opioids dispensed by a pharmacist, including an opioid 
621antagonist dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to 
622be reimbursed under the medical benefit shall not exceed the carrier’s average in-network 
623pharmacy benefit rate and the health care facility shall not balance bill the patient.
624 Section 47WW. Any policy, contract, agreement, plan or certificate of insurance issued, 
625delivered or renewed within the commonwealth, which is considered creditable coverage under 
626section 1 of chapter 111M, shall provide coverage for the provision of services by a recovery 
627coach licensed or otherwise authorized to practice under chapter 111J, irrespective of the setting 
628in which these services are provided; provided, that such services shall be within the lawful 
629scope of practice of a recovery coach. The contractual rate for these services shall be no less than 
630the prevailing MassHealth rate for recovery coach services. The benefits in this section shall not 
631be subject to any deductible, coinsurance, copayments or out-of-pocket limits; provided, 
632however, that cost-sharing 	shall be required if the applicable plan is governed by the federal 
633Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition on cost-
634sharing for this service. Recovery coach services shall be deemed medically necessary and shall 
635not require prior authorization. 31 of 47
636 SECTION 15. Said chapter 175 is hereby further amended by inserting after section 
637122A the following section:- 
638 Section 122B. (a) No insurer authorized to issue policies on the lives of persons in the 
639commonwealth shall make a distinction or otherwise discriminate between persons, reject an 
640applicant, cancel a policy or demand or require a higher rate of premium for reasons based solely 
641upon an applicant or insured having or had a prescription for, purchased or otherwise possessed 
642an opioid antagonist, as defined in section 19B of chapter 94C. 
643 (b) A violation of this section shall constitute an unfair method of competition or unfair 
644and deceptive act or practice pursuant to chapters 93A and 176D.
645 SECTION 15A. Chapter 176A of the General Laws is hereby amended by striking out 
646section 8MM and inserting in place thereof the following section:-
647 Section 8MM. (a) Any contract between a subscriber and the corporation under an 
648individual or group hospital service plan that is delivered, issued or renewed within the 
649commonwealth shall develop a plan to provide adequate coverage and access to a broad 
650spectrum of pain management services, including, but not limited to, non-medication, non-
651surgical treatment modalities and non-opioid medication treatment options that serve as 
652alternatives to opioid prescribing, in accordance with guidelines developed by the division of 
653insurance.
654 (b) No such contract shall, relative to pain management services identified by the carrier 
655pursuant to subsection (a), require a member to obtain a preauthorization for non-medication, 
656non-surgical treatment modalities that include restorative therapies, behavioral health approaches  32 of 47
657or integrative health therapies, including acupuncture, chiropractic treatments, massage, and 
658movement therapies.
659 (c)(1) The plan pursuant to subsection (a) shall be subject to approval and shall be a 
660component of carrier accreditation by the division of insurance pursuant to section 2 of chapter 
661176O. In its review, the division shall consider the adequacy of access to a broad spectrum of 
662pain management services and any carrier policies that may create unduly preferential coverage 
663to prescribing opioids without other pain management modalities.
664 (2) No contract between a subscriber and the corporation under an individual or group 
665hospital service plan that is delivered, issued or renewed within the commonwealth shall 
666establish utilization controls, including preauthorization or step therapy requirements, for 
667clinically appropriate non-opioid drugs approved by the federal Food and Drug Administration 
668for the treatment or management of pain, that are more restrictive or extensive than the least 
669restrictive or extensive utilization controls applicable to any clinically appropriate opioid drug.
670 (d) Carriers shall annually distribute educational materials to providers within their 
671networks and to members about the pain management access plan and shall make information 
672about their plans publicly available on their websites.
673 SECTION 16. Said chapter 176A is hereby further amended by inserting after section 
6748VV the following 2 sections:- 
675 Section 8WW. Any contract between a subscriber and the corporation under an 
676individual or group hospital service plan that is delivered, issued or renewed within the 
677commonwealth shall provide coverage for prescribed or dispensed opioid antagonists, as defined  33 of 47
678in section 19B of chapter 94C and used in the reversal of overdoses caused by opioids, which 
679shall be deemed medically necessary and shall not require prior authorization; provided, 
680however, that a prescription from a health care practitioner shall not be required for coverage of 
681opioid antagonists. An opioid antagonist used in the reversal of overdoses caused by opioids 
682shall not be subject to any deductible, coinsurance, copayments or out-of-pocket limits; 
683provided, however, that cost-sharing shall be required if the applicable plan is governed by the 
684federal Internal Revenue Code and would lose its tax-exempt status as a result of the prohibition 
685on cost-sharing for this service. 
686 (b) Such contract shall provide coverage for an opioid antagonist used in the reversal of 
687overdoses caused by opioids as a medical benefit when dispensed by the health care facility in 
688which the opioid antagonist was prescribed and shall provide coverage as a pharmacy benefit for 
689an opioid antagonist used in the reversal of overdoses caused by opioids dispensed by a 
690pharmacist, including an opioid antagonist dispensed pursuant to section 19B of chapter 94C; 
691provided, however, that the rate to be reimbursed under the medical benefit shall not exceed the 
692carrier’s average in-network pharmacy benefit rate and the health care facility shall not balance 
693bill the patient.
694 Section 8XX. Any contract between a subscriber and the corporation under an individual 
695or group hospital service plan that is delivered, issued or renewed within the commonwealth 
696shall provide coverage for the provision of services by a recovery coach licensed or otherwise 
697authorized to practice under chapter 111J, irrespective of the setting in which these services are 
698provided; provided, that such services shall be within 	the lawful scope of practice of a recovery 
699coach. The contractual rate for these services shall be no less than the prevailing MassHealth rate 
700for recovery coach services. The benefits in this section shall not be subject to any deductible,  34 of 47
701coinsurance, copayments or out-of-pocket limits; provided, however, that cost-sharing shall be 
702required if the applicable plan is governed by the federal Internal Revenue Code and would lose 
703its tax-exempt status as a result of the prohibition on cost-sharing for this service. Recovery 
704coach services shall be deemed medically necessary and shall not require prior authorization.
705 SECTION 16A. Chapter 176B of the General Laws is hereby amended by striking out 
706section 4MM and inserting in place thereof the following section:-
707 Section 4MM. (a) Any subscription certificate under an individual or group medical 
708service agreement delivered, issued or renewed within the commonwealth shall develop a plan to 
709provide adequate coverage and access to a broad spectrum of pain management services, 
710including, but not limited to, non-medication, non-surgical treatment modalities and non-opioid 
711medication treatment options that serve as alternatives to opioid prescribing, in accordance with 
712guidelines developed by the division of insurance.
713 (b) No such subscription certificate shall, relative to pain management services identified 
714by the carrier pursuant to subsection (a), require a member to obtain a preauthorization for non-
715medication, non-surgical treatment modalities that include restorative therapies, behavioral 
716health approaches or integrative health therapies, including acupuncture, chiropractic treatments, 
717massage, and movement therapies.
718 (c)(1) The plan pursuant to subsection (a) shall be subject to approval and shall be a 
719component of carrier accreditation by the division of insurance pursuant to section 2 of chapter 
720176O. In its review, the division shall consider the adequacy of access to a broad spectrum of 
721pain management services and any carrier policies that may create unduly preferential coverage 
722to prescribing opioids without other pain management modalities. 35 of 47
723 (2) No subscription certificate under an individual or group medical service agreement 
724delivered, issued or renewed within the commonwealth shall establish utilization controls, 
725including preauthorization or step therapy requirements, for clinically appropriate non-opioid 
726drugs approved by the federal Food and Drug Administration for the treatment or management of 
727pain, that are more restrictive or extensive than the least restrictive or extensive utilization 
728controls applicable to any clinically appropriate opioid drug.
729 (d) Carriers shall annually distribute educational materials to providers within their 
730networks and to members about the pain management access plan and shall make information 
731about their plans publicly available on their websites.
732 SECTION 17. Said chapter 176B is hereby further amended by inserting after section 
7334VV the following 2 sections:- 
734 Section 4WW. Any subscription certificate under an individual or group medical service 
735agreement delivered, issued or renewed within the commonwealth, shall provide coverage for 
736prescribed or dispensed opioid antagonists, as defined in section 19B of chapter 94C and used in 
737the reversal of overdoses caused by opioids, which shall be deemed medically necessary and 
738shall not require prior authorization; provided, however, that a prescription from a health care 
739practitioner shall not be required for coverage of opioid antagonists. An opioid antagonist used in 
740the reversal of overdoses caused by opioids shall not be subject to any deductible, coinsurance, 
741copayments or out-of-pocket limits; provided, however, that cost-sharing shall be required if the 
742applicable plan is governed by the federal Internal Revenue Code and would lose its tax-exempt 
743status as a result of the prohibition on cost-sharing for this service.  36 of 47
744 (b) The policy, contract, agreement, plan or certificate of insurance shall provide 
745coverage for an opioid antagonist used in the reversal of overdoses caused by opioids as a 
746medical benefit when dispensed by the health care facility in which the opioid antagonist was 
747prescribed and shall provide coverage as a pharmacy benefit for an opioid antagonist used in the 
748reversal of overdoses caused by opioids dispensed by a pharmacist, including an opioid 
749antagonist dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to 
750be reimbursed under the medical benefit shall not exceed the carrier’s average in-network 
751pharmacy benefit rate and the health care facility shall not balance bill the patient.
752 Section 4XX. Any subscription certificate under an individual or group medical service 
753agreement delivered, issued or renewed within the commonwealth shall provide coverage for the 
754provision of services by a recovery coach licensed or otherwise authorized to practice under 
755chapter 111J, irrespective of the setting in which these services are provided; provided, that such 
756services shall be within the lawful scope of practice of a recovery coach. The contractual rate for 
757these services shall be no less than the prevailing MassHealth rate for recovery coach services. 
758The benefits in this section shall not be subject to any deductible, coinsurance, copayments or 
759out-of-pocket limits; provided, however, that cost-sharing shall be required if the applicable plan 
760is governed by the federal Internal Revenue Code and would lose its tax-exempt status as a result 
761of the prohibition on cost-sharing for this service. Recovery coach services shall be deemed 
762medically necessary and shall not require prior authorization.
763 SECTION 17A. Chapter 176G of the General Laws is hereby amended by striking out 
764section 4EE and inserting in place thereof the following section:- 37 of 47
765 Section 4EE. (a) Any individual or group health maintenance contract that is issued or 
766renewed within or without 	the commonwealth shall develop a plan to provide adequate coverage 
767and access to a broad spectrum of pain management services, including, but not limited to, non-
768medication, non-surgical treatment modalities and non-opioid medication treatment options that 
769serve as alternatives to opioid prescribing, in accordance with guidelines developed by the 
770division of insurance.
771 (b) No such contract shall, relative to pain management services identified by the carrier 
772pursuant to subsection (a), require a member to obtain a preauthorization for non-medication, 
773non-surgical treatment modalities that include restorative therapies, behavioral health approaches 
774or integrative health therapies, including acupuncture, chiropractic treatments, massage, and 
775movement therapies.
776 (c)(1) The plan pursuant to subsection (a) shall be subject to approval and shall be a 
777component of carrier accreditation by the division of insurance pursuant to section 2 of chapter 
778176O. In its review, the division shall consider the adequacy of access to a broad spectrum of 
779pain management services and any carrier policies that may create unduly preferential coverage 
780to prescribing opioids without other pain management modalities.
781 (2) No individual or group health maintenance contract that is issued or renewed within 
782or without the commonwealth shall establish utilization controls, including preauthorization or 
783step therapy requirements, for clinically appropriate non-opioid drugs approved by the federal 
784Food and Drug Administration for the treatment or management of pain, that are more restrictive 
785or extensive than the least restrictive or extensive utilization controls applicable to any clinically 
786appropriate opioid drug. 38 of 47
787 (d) Carriers shall annually distribute educational materials to providers within their 
788networks and to members about the pain management access plan and shall make information 
789about their plans publicly available on their websites.
790 SECTION 18. Said chapter 176G is hereby further amended by inserting after section 
7914NN the following 2 sections:- 
792 Section 4OO. An individual or group health maintenance contract that is issued or 
793renewed within or without 	the commonwealth shall provide coverage for prescribed or dispensed 
794opioid antagonists, as defined in section 19B of chapter 94C and used in the reversal of 
795overdoses caused by opioids, which shall be deemed medically necessary and shall not require 
796prior authorization; provided, however, that a prescription from a health care practitioner shall 
797not be required for coverage of opioid antagonists. An opioid antagonist used in the reversal of 
798overdoses caused by opioids shall not be subject to any deductible, coinsurance, copayments or 
799out-of-pocket limits; provided, however, that cost-sharing shall be required if the applicable plan 
800is governed by the federal Internal Revenue Code and would lose its tax-exempt status as a result 
801of the prohibition on cost-sharing for this service. 
802 (b) The individual or group health maintenance contract shall provide coverage for an 
803opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when 
804dispensed by the health care facility in which the opioid antagonist was prescribed and shall 
805provide coverage as a pharmacy benefit for an opioid antagonist used in the reversal of 
806overdoses caused by opioids dispensed by a pharmacist, including an opioid antagonist 
807dispensed pursuant to section 19B of chapter 94C; provided, however, that the rate to be  39 of 47
808reimbursed under the medical benefit shall not exceed the carrier’s average in-network pharmacy 
809benefit rate and the health care facility shall not balance bill the patient.
810 Section 4PP. An individual or group health maintenance contract that is issued or 
811renewed within or without 	the commonwealth shall provide coverage for the provision of 
812services by a recovery coach licensed or otherwise authorized to practice under chapter 111J, 
813irrespective of the setting in which these services are provided; provided, that such services shall 
814be within the lawful scope of practice of a recovery coach. The contractual rate for these services 
815shall be no less than the prevailing MassHealth rate for recovery coach services. The benefits in 
816this section shall not be subject to any deductible, coinsurance, copayments or out-of-pocket 
817limits; provided, however, that cost-sharing shall be required if the applicable plan is governed 
818by the federal Internal Revenue Code and would lose its tax-exempt status as a result of the 
819prohibition on cost-sharing for this service. Recovery coach services shall be deemed medically 
820necessary and shall not require prior authorization.
821 SECTION 18A. (a) Notwithstanding any general or special law to the contrary, the 
822Massachusetts alcohol and substance abuse center, hereinafter referred to as the center, shall be 
823considered a security facility under section 35 of chapter 123 of the General Laws for the 
824purposes of commitments under said section 35 until the conditions under subsection (b) are 
825satisfied.
826 (b) The secretary of health and human services shall develop a plan to end operations at 
827the center as a facility accepting persons committed for treatment for alcohol or substance use 
828disorder by not later than December 31, 2026; provided, however, that persons may continue to 
829be committed to the center under said section 35 of said chapter 123 until the department of  40 of 47
830public health and department of mental health have licensed and approved suitable facilities with 
831a total bed capacity equal to the center. Such facilities shall be geographically distributed so as to 
832provide access to treatment in all regions of the commonwealth.
833 (c) The secretary shall submit the plan required under subsection (b) to the clerks of the 
834senate and house of representatives and to the joint committee on mental health, substance abuse 
835and recovery not later than 180 days after the effective date of this act. The secretary shall submit 
836interim reports quarterly detailing the progress towards ending operations at the center to the 
837clerks of the senate and house of representatives and to the joint committee on mental health, 
838substance abuse and recovery. The quarterly reports shall include, but shall not be limited to 
839following: (i) a census of persons being treated at the center; (ii) the number of persons 
840transferred from the center to other facilities licensed by the department of public health or 
841department of mental health; (iii) the location and bed capacity of each newly licensed facility; 
842(iv) the type of facility and location of newly committed persons under section 35 of chapter 123 
843of the General Laws; and (v) the anticipated fiscal impact, if any, of complying with this section.
844 SECTION 19. (a) The department of children and families, in consultation with the 
845department of public health and the office of the child advocate, shall promulgate regulations or 
846issue further guidance for the requirements of health care providers involved in the delivery or 
847care of infants identified as being affected by prenatal substance exposure or fetal alcohol 
848spectrum disorder. The regulations or guidance shall include, but shall not be limited to: (i) 
849factors for determining instances in which prenatal substance exposure from a medication 
850prescribed by a licensed health care provider require filing a report pursuant to section 51A of 
851chapter 119 of the General Laws; provided, that an indication of prenatal substance exposure 
852shall not solely meet the requirements of said section 51A of said chapter 119; and (ii) the roles  41 of 47
853and responsibilities of health care providers and staff who care for perinatal patients or newborns 
854pursuant to 42 U.S.C. § 5106a(b)(2)(B)(ii) and in accordance with the federal Child Abuse 
855Prevention and Treatment Act, 42 U.S.C. § 5101 et seq. and 42 U.S.C. § 5116 et seq., as 
856amended from time to time.
857 (b) Such regulations or guidance shall: (i) reflect current accepted standards of health 
858care and substance use treatment practices; (ii) conform to the reporting requirements under the 
859federal Child Abuse Prevention and Treatment Act, 42 U.S.C. § 5101 et seq. and 42 U.S.C. § 
8605116 et seq., as amended from time to time; and (iii) to the extent possible, reduce racial 
861disparities in maternal and child health care, reports of suspected child abuse or neglect under 
862said section 51A of said chapter 119 or the number of patients identified for plans of safe care 
863pursuant to the federal Child Abuse Prevention and Treatment Act, 42 U.S.C. § 5101 et seq. and 
86442 U.S.C. § 5116 et seq., as amended from time to time. 
865 (c) Such regulations or guidance shall be developed with input from relevant 
866stakeholders, including, but not limited to: (i) medical professional associations and health care 
867providers with expertise in the provision of care to pregnant people; (ii) individuals who have 
868lived experience of seeking or receiving behavioral health services or treatment prior to, during 
869and after pregnancy; (iii) professional associations and organizations with expertise in prenatal 
870substance exposure, perinatal and child health, treatment of substance use disorder and racial 
871equity in access to health care; and (iv) behavioral health professionals with expertise in 
872providing culturally-competent care.
873 SECTION 20. The 	bureau of substance addiction services within the department of 
874public health shall conduct a comprehensive review of barriers to certification, credentialing and  42 of 47
875other employment and practice requirements of recovery coaches, including, but not limited to, 
876peer support specialists, peer recovery coaches and recovery support navigators, and issue a 
877report on its findings. The report shall include, but shall not be limited to: (i) cost barriers for 
878individuals with lived experience, including, but not limited to, application and examination fees 
879for initial certification and credentialing; (ii) cost barriers to certification and credentialing 
880renewals; (iii) cost and reimbursement barriers for hospitals and clinics licensed under chapter 
881111 of the General Laws and other employers to hire, train and retain recovery coaches, 
882including, but not limited to, peer support specialists, peer recovery coaches and recovery 
883support navigators; (iv) eligibility requirements for certification and credentialing; (v) access to 
884training programs and resources; and (vi) any additional barriers to obtaining and maintaining 
885authorization to practice recovery coaching. The report shall also include recommendations to 
886address said barriers. The bureau shall submit a copy of the report to the secretary of health and 
887human services, the clerks of the house of representatives and the senate and the joint committee 
888on mental health, substance use and recovery within 90 days of the effective date of this act.
889 SECTION 20A. (a) The bureau of substance addiction services within the department of 
890public health shall review and study the disparate impacts and disparities of substance use 
891disorder, overdoses, overdose deaths and clinical outcomes for members of historically 
892marginalized communities, including, but not limited to, impacts based on race, ethnicity, 
893language, gender, gender identity, sexual orientation, age, disability and other social 
894determinants of health identified by the bureau.
895 (b) The bureau shall: (i) review current data and trends regarding substance use and 
896overdose rates, disparities in treatment access and corresponding causes within historically 
897marginalized communities; (ii) evaluate the effectiveness of current treatment interventions  43 of 47
898within historically marginalized communities; (iii) identify barriers to accessing treatment, 
899including, but not limited to, access to necessary resources, education and access to appropriate 
900care and interventions; and (iv) identify evidence-based strategies to reduce overdose deaths and 
901improve access, treatment and education within historically marginalized communities.
902 (c) Not later than June 30, 2025, the bureau shall submit a report of its findings and any 
903recommendations, including any legislative or regulatory changes that may be necessary to carry 
904out any recommendations, to the clerks of the house of representatives and the senate, the joint 
905committee on mental health, substance use and recovery and the joint committee on racial equity, 
906civil rights, and inclusion.
907 SECTION 20B. (a) For the purposes of this section, the words “administrative discharge” 
908shall mean the termination 	of treatment of a patient determined by a health care provider to have 
909a substance use disorder and related treatment needs despite a lack of clinical improvement in the 
910patient due to a violation of an administrative rule of a licensed substance use disorder treatment 
911program.
912 (b) The bureau of substance addiction services within the department of public health 
913shall study the circumstances and effects of administrative discharges of patients from substance 
914use disorder treatment programs licensed under sections 6 and 6A of chapter 111B of the 
915General Laws or section 7 of chapter 111E of the General Laws or programs established 
916pursuant to sections 24 and 24D of chapter 90.
917 (b) The bureau shall examine: (i) standards used by substance use disorder treatment 
918programs in determining when an administrative discharge is appropriate, including, but not 
919limited to, any standard criteria, methodology or graduated sanctions based on staff and patient  44 of 47
920safety and the level of treatment and severity of the symptoms of the patient; (ii) options for 
921patients following an administrative discharge from a substance use disorder treatment program, 
922including, but not limited to, any programs or resources available to a patient and the frequency 
923that such options are provided to said patients; and (iii) the applicability, availability and 
924effectiveness of the regulations relative to the coordination of care and management of discharge 
925planning for an administrative discharge pursuant to 105 CMR 164 and section 19 of chapter 17 
926of the General Laws.
927 (c) Not later than December 31, 2025, the bureau shall submit its findings and any 
928recommendations, including any legislative or regulatory changes that may be necessary to 
929implement any recommendations, with the clerks of the house of representatives and senate, the 
930house and senate committees on ways and means and the joint committee on mental health, 
931substance use and recovery.
932 SECTION 21. (a) The department of public health may issue a recovery coach license to 
933an applicant who: (i) is practicing in the commonwealth as a recovery coach as of the effective 
934date of this act; and (ii) applies for licensure within 1 year of the effective date of this act. The 
935lived experience requirement pursuant to section 1 of chapter 111J of the General Laws, as 
936inserted by section 10, shall be waived for applicants who were credentialed by the 
937Massachusetts Board of Substance Abuse Counselor Certification prior to the effective date of 
938this act.
939 (b) The department of public health shall issue a temporary recovery coach license to an 
940applicant who has received a Certified Addictions Recovery Coach certification, issued by the 
941Massachusetts Board of Substance Abuse Counselor Certification and provides satisfactory proof  45 of 47
942for any test or examination that may be required for licensure; provided, that no temporary 
943license shall be valid for more than 2 years. The applicants eligible for a temporary license shall 
944meet all other qualifications and requirements for licensure as determined by the department of 
945public health.
946 (c) The department of public health shall promulgate rules or regulations for the 
947implementation of this section.
948 SECTION 21A. (a) There is hereby established a special commission to study and make 
949recommendations on ways to address the public health and safety concerns posed by the 
950proliferation of xylazine as an additive to illicit drugs such as fentanyl.
951 (b) The commission shall consist of the following 13 members: the chairs of the joint 
952committee on mental health, substance use, and recovery, who shall serve as co-chairs; 1 
953member appointed by the speaker of the house of representatives; 1 member appointed by the 
954minority leader of the house of representatives; 1 member appointed by the senate president; 1 
955member appointed by the minority leader of the senate; the secretary of health and human 
956services, or their designee; the commissioner of public health, or their designee; the 
957commissioner of mental health, or their designee; the secretary of public safety and security, or 
958their designee; 1 member who is a representative of the bureau of substance addiction services 
959within the department of public health; 1 member who is a representative of the Massachusetts 
960Veterinary Medical Association; and 1 member appointed by the governor who shall be a 
961registered nurse or licensed physician with experience in treating patients for substance use 
962disorder. 46 of 47
963 (c) The commission shall consider: (i) best practices to regulate and oversee the 
964production and distribution of xylazine to ensure that it is used solely for its intended purpose as 
965an animal tranquilizer administered by licensed veterinarians and not for human consumption; 
966(ii) whether xylazine should be classified as a controlled substance and appropriate penalties for 
967its illegal production and distribution; (iii) the availability of effective outreach and treatment 
968programs for patients who have been exposed to xylazine and ways to address any gaps in 
969available programs and services; and (iv) any other considerations determined to be relevant by 
970the commission.
971 (d) The commission shall file a report and its recommendations, including any legislation 
972necessary to implement the recommendations, with the clerks of the house of representatives and 
973the senate not later than June 30, 2025.
974 SECTION 22. No person shall be found to have violated section 4 of chapter 111J of the 
975General Laws, as inserted by section 10, until 6 months after the department of public health first 
976issues a recovery coach license pursuant to said section 4 of said chapter 111J.
977 SECTION 23. Not later than 18 months after the effective date of this act, the initial 
978report consistent with the report required pursuant to section 110D of chapter 111 of the General 
979Laws, as inserted by section 8, shall be filed by the department of public health, in consultation 
980with the department of children and families and the office of the child advocate, with the clerks 
981of the house of representatives and the senate, the house and senate committees on ways and 
982means, the joint committee on children, families and person with disabilities and the joint 
983committee on mental health, substance use and recovery examining the prevalence of births of  47 of 47
984infants identified as being affected by prenatal substance exposure or fetal alcohol spectrum 
985disorder.
986 SECTION 23A. All commission members pursuant to section 21A shall be appointed 
987within 30 days of the effective date of this act.